Concepedia

Masaya Miyamoto

MM

8

Publications

330

Citations

8

H-Index

2013

Active since

Affiliations

The University of Tokyo(Current)

Daiichi-Sankyo (Japan)

Masaya Miyamoto is an author at The University of Tokyo specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2013–2023

8

Publications

8

The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models

Ryohei Katayama, Bo Gong, Noriko Togashi et al. · Nature Communications · 2019 · 135 citations · Full text

REG4 is a transcriptional target of GATA6 and is essential for colorectal tumorigenesis

Yoshihiro Kawasaki, Kosuke Matsumura, Masaya Miyamoto et al. · Scientific Reports · 2015 · 51 citations · Full text

, , +15

The miR-1-NOTCH3-Asef Pathway Is Important for Colorectal Tumor Cell Migration

Shiori Furukawa, Yoshihiro Kawasaki, Masaya Miyamoto et al. · PLoS ONE · 2013 · 48 citations · Full text

, , +12

The novel lnc <scp>RNA</scp> <i> <scp>CALIC</scp> </i> upregulates <scp>AXL</scp> to promote colon cancer metastasis

Yoshihiro Kawasaki, Masaya Miyamoto, Takeaki Oda et al. · EMBO Reports · 2019 · 37 citations · Full text

, , +8

Highly potent, orally active novel small-molecule HPK1 inhibitor DS21150768 induces anti-tumor responses in multiple syngeneic tumor mouse models

Genzui Setsu, Megumi Goto, Kentaro Ito et al. · European Journal of Pharmacology · 2023 · 18 citations

, , +9

Rows per page

1–5 of 8